Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: methotrexate

TNF Inhibitors & RA

Richard Quinn  |  March 24, 2014

Anti-tumor necrosis factor agents may have cardioprotective effects in rheumatoid arthritis patients

Filed under:Uncategorized Tagged with:acute coronary syndromeanti-tumor necrosis factorRheumatoid arthritisTNF

Approval Expected for Apremilast

Richard Quinn  |  March 5, 2014

New drug shows promise in treating psoriatic arthritis, ankylosing spondylitis & psoriasis

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesOther Rheumatic ConditionsPsoriatic Arthritis Tagged with:Ankylosing SpondylitisapremilastCelgene Corp.PsoriasisPsoriatic Arthritis

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

Filed under:Axial SpondyloarthritisConditionsDrug UpdatesOsteoarthritis and Bone DisordersPsoriatic ArthritisRheumatoid Arthritis Tagged with:Ankylosing Spondylitisanti-inflammatoryApprovalsdrugFDAMethotrexateOsteoarthritisPipelinePsoriatic ArthritisRheumatoid arthritisrheumatologistrheumatologySafety

Switches That Regulate Gene Expression Offer Better Understanding of Rheumatic Disease Say Experts at the 2013 ACR/ARHP Annual Meeting

Mary Beth Nierengarten  |  March 1, 2014

New studies examine why turning on or off switches in genes that control the genome can contribute to pathogenesis of such autoimmune diseases as systemic lupus erythematosus or rheumatoid arthritis

Filed under:ConditionsMeeting ReportsResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:ACR/ARHP Annual MeetingAutoimmune diseasedruggenomeLupusMethotrexateResearchRheumatic DiseaseRheumatoid arthritisSystemic lupus erythematosus

Causes of Alopecia Can Vary Among Patients with Systemic Disease Say Experts at the 2013 ACR/ARHP Annual Meeting

Susan Bernstein  |  March 1, 2014

Beyond such autoimmune diseases as systemic lupus erythematosus and rheumatoid arthritis, rheumatologists should consider hypothyroidism, dietary issues, and grooming habits in patients with hair loss

Filed under:ConditionsMeeting ReportsRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RACR/ARHP Annual MeetingalopeciaAmerican College of Rheumatology (ACR)anti-inflammatoryCausedrugHYDROXYCHLOROQUINELupusMethotrexatepatient careRheumatic DiseaseRheumatoid arthritisSystemic lupus erythematosus

Microbiome Research Provides Clue to Rheumatoid Arthritis

Lara C. Pullen, PhD  |  February 20, 2014

A new study suggests that intestinal expansion of Prevotella copri may be associated with the pathogenesis of RA

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:MicrobiomePathogenesisPrevotella copriResearchRheumatoid arthritis

2013 ACR/ARHP Annual Meeting: Inflammatory Eye Disease Management Can Benefit from Collaboration between Rheumatologists and Ophthalmologists

Susan Bernstein  |  February 1, 2014

Joint effort is critical to diagnosing and treating uveitis, iritis, and other autoimmune eye disorders in patients with inflammatory disease

Filed under:ConditionsMeeting ReportsRheumatoid Arthritis Tagged with:ACR/ARHP Annual MeetingDiagnosisInflammatory Eye DiseaseOphthalmologistpatient carerheumatologistTreatmentUveitis

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  January 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesResearch RheumRheumatoid Arthritis Tagged with:Ankylosing Spondylitisanti-inflammatoryApprovalsaxial spondyloarthritis (SpA)BiologicsdrugFDAMethotrexateResearchRheumatoid arthritisrheumatologistrheumatologySafetytocilizumab

Fellow’s Forum Case Report: Arthritis, Fever, and Weight Loss In a Teenager Suggest A Rheumatic Condition

Jonathan S. Hausmann, MD  |  January 1, 2014

Joint pain and swelling flare up in a 14-year-old boy who tests positive for inflammation, thrombocytosis, and human leukocyte antigen B27

Filed under:Axial SpondyloarthritisConditionsPediatric ConditionsRheumatoid Arthritis Tagged with:anti-inflammatoryautoinflammatoryClinicalDiagnosisdrugfeverlabsMethotrexatepatient carePediatricprednisoneReactive arthritistocilizumabweight loss

Rheuminations: Why the Obesity Epidemic Should Matter to Rheumatologists

Simon M. Helfgott, MD  |  January 1, 2014

As changes in diet and eating habits have caused obesity rates to soar, research into the metabolic syndrome suggests obesity may be a form of a low-grade inflammatory state

Filed under:OpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:anti-inflammatoryeatingepidemicHelfgottMethotrexateObesitypatient careResearchrheumatologistrheumatology

  • « Previous Page
  • 1
  • …
  • 83
  • 84
  • 85
  • 86
  • 87
  • …
  • 107
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences